ResMed Inc.RMDNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +10.26% | +7.92% | +10.20% | +9.07% | +10.98% |
| Gross Profit Growth | +12.23% | +12.45% | +16.44% | +14.44% | +17.75% |
| EBITDA Growth | +27.00% | +9.41% | +46.91% | +13.68% | +18.25% |
| Operating Income Growth | +51.67% | +13.80% | +19.23% | +15.29% | +19.26% |
| Net Income Growth | +65.05% | +21.48% | +29.93% | +11.94% | +13.92% |
| EPS Growth | +65.49% | +22.06% | +30.15% | +12.26% | +14.47% |
| EPS Diluted Growth | +64.79% | +21.57% | +30.30% | +12.32% | +14.53% |
| Weighted Average Shares Growth | -0.18% | -0.16% | -0.30% | -0.26% | -0.26% |
| Weighted Average Shares Diluted Growth | +0.04% | -0.16% | -0.34% | -0.38% | -0.38% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +13.12% | +43.93% | +22.42% | +40.48% | +10.08% |
| Free Cash Flow Growth | +16.14% | +46.43% | +22.81% | +35.44% | +7.41% |
| Receivables Growth | +25.57% | +20.56% | +13.16% | +18.15% | +2.70% |
| Inventory Growth | -21.92% | +4.00% | +12.83% | +3.03% | +4.53% |
| Asset Growth | +3.42% | +11.04% | +18.95% | +15.04% | +19.07% |
| Book Value per Share Growth | +17.42% | +19.98% | +23.06% | +18.14% | +20.65% |
| Debt Growth | -39.65% | -28.07% | -2.53% | -0.46% | +19.31% |
| R&D Expense Growth | +10.14% | +8.91% | +6.90% | +9.81% | +11.79% |
| SG&A Expenses Growth | +8.76% | +6.69% | +9.47% | +8.46% | +15.22% |